13F Holdings
中文EN

Alphabet Inc.

Mountain View CA · SEC CIK 0001652044

2026Q22026Q1 9 earlier quarters 🔒
$99.08B2026Q2 reported value
28Positions
99.5%Top 10 weight · largest 95.0%
0 / 1New / sold out

Estimated portfolio return 2024Q3 – 2026Q2, 8 quarters

+138.5% S&P 500 +37.2%

Corporate holdings: this filer's 13F is mainly the company's own portfolio, so the return is for reference only and it is not in the performance ranking.

— Fund - - S&P 500 (SPY price return) · Full history on paid plans 🔒

Quarter2024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Fund-3.8%+5.8%-12.9%+38.3%+19.6%+22.8%+10.9%+19.5%
S&P 500+5.4%+2.1%-4.6%+10.5%+7.8%+2.4%-4.6%+14.8%
Coverage100%100%100%100%100%92%100%100%

Estimated from quarter-end holdings and 13F reported values; excludes intra-quarter trading, dividends and fees — for reference only. Quarterly return = price change (implied by 13F filings) of the stocks held at the previous quarter end, value-weighted; coverage = share of holdings with a computable price change. Quarters below 70% coverage or with fewer than 5 stocks are not counted (shown as —).

Reported value over time$99.08B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

SPCX 95.0%
PL 1.2%
ASTS 0.8%
CME 0.8%
ARM 0.7%
RVMD 0.6%
FRSH 0.2%
PBLS 0.1%
TEM 0.1%
GTLB 0.1%

2026Q2 top buys estimated at quarter-end value

No buys this quarter

2026Q2 top sells estimated at quarter-end value

RVMD Reduced-$64.78M
GLUE Reduced-$7.55M
RLAY Reduced-$2.88M
LIFE Reduced-$2.68M
TENAYA THERAPEUT Sold out-$631,836

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
SPCX SPACE EXPLORATION TECHN CORP $94.18B95.05%551,189,500 551,189,500— — First reported
PL PLANET LABS PBC $1.17B1.18%35,248,893 00.0% — Unchanged
ASTS AST SPACEMOBILE INC $794.72M0.80%8,943,486 00.0% — Unchanged
CME CME GROUP INC $769.38M0.78%3,484,020 00.0% — Unchanged
ARM ARM HOLDINGS PLC $695.24M0.70%1,960,784 00.0% — Unchanged
RVMD REVOLUTION MEDICINES INC $551.84M0.56%2,946,619 -345,906-10.5% -$64.78M Reduced
FRSH FRESHWORKS INC $164.01M0.17%16,206,643 00.0% — Unchanged
PBLS PARABILIS MEDICINES INC $134.65M0.14%4,919,498 4,919,498— — First reported
TEM TEMPUS AI INC $89.86M0.09%1,551,102 00.0% — Unchanged
GTLB GITLAB INC $83.19M0.08%2,724,712 00.0% — Unchanged
PATH UIPATH INC $76.46M0.08%7,034,337 00.0% — Unchanged
LIFE ETHOS TECHNOLOGIES INC $65.71M0.07%3,622,604 -147,552-3.9% -$2.68M Reduced
PRME PRIME MEDICINE INC $61.12M0.06%16,562,498 00.0% — Unchanged
FRVO FERVO ENERGY CO $51.47M0.05%1,760,732 1,760,732— — First reported
PAYP PAYPAY CORP $44.78M0.05%3,125,000 00.0% — Unchanged
MAZE MAZE THERAPEUTICS INC $41.44M0.04%1,388,583 00.0% — Unchanged
RLAY RELAY THERAPEUTICS INC $26.38M0.03%1,410,029 -154,144-9.9% -$2.88M Reduced
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $21.51M0.02%2,823,126 00.0% — Unchanged
OSCR OSCAR HEALTH INC $13.75M0.01%481,988 00.0% — Unchanged
BEAM BEAM THERAPEUTICS INC $11.04M0.01%321,604 00.0% — Unchanged
VERA VERA THERAPEUTICS INC $10.35M0.01%241,264 00.0% — Unchanged
SANA SANA BIOTECHNOLOGY INC $9.82M0.01%2,812,500 00.0% — Unchanged
GLUE MONTE ROSA THERAPEUTICS INC $9.01M0.01%372,474 -311,801-45.6% -$7.55M Reduced
LYEL LYELL IMMUNOPHARMA INC $4.12M0.00%293,256 00.0% — Unchanged
FIG FIGMA INC $3.90M0.00%215,582 00.0% — Unchanged
— SPERO THERAPEUTICS INC $1.97M0.00%889,979 00.0% — Unchanged
— HYPERFINE INC $1.21M0.00%898,720 00.0% — Unchanged
AUTL AUTOLUS THERAPEUTICS PLC $1.12M0.00%698,262 00.0% — Unchanged
— TENAYA THERAPEUTICS INC $00.00%0 -915,705-100.0% -$631,836 Sold out